Get started
Author

Kazuki Otake

Observed name: Otake, Kazuki
ORCID: 0009-0006-1225-5133
Observed ORCID: 0009-0006-1225-5133
OpenAlex ID: A5003049161
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor
2023 · Kazuki Otake, Minoru Ubukata, et al. · ACS Medicinal Chemistry Letters · 29
PDF
Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors
2024 · Kazuki Otake, Yoshinori Hara, et al. · Journal of Medicinal Chemistry · 12
Screening approaches for the identification of Nrf2-Keap1 protein-protein interaction inhibitors targeting hot spot residues
2023 · Wataru Asano, Rie Hantani, et al. · SLAS DISCOVERY · 11
PDF
A Concise and Modular Approach to Generate Novel RORγ Agonists
2025 · Shunichi Fukuda, Taku Ikenogami, et al. · Journal of Medicinal Chemistry · 2
Discovery of a Phosphodiesterase 7A Inhibitor of High Isozyme Selectivity Exhibiting In Vivo Anti-Osteoporotic Effects
2024 · Kentaro Kondo, Kazuki Otake, et al. · ACS Medicinal Chemistry Letters · 1
PDF
Protective function of the voltage-gated potassium channel Kv11.3 in a mouse model of cardiac ischemia/reperfusion injury
2025 · Hayato Sasaki, Kazuki Otake, et al. · PLoS ONE
PDF
Correction to “Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein–Protein Interaction Inhibitors”
2024 · Kazuki Otake, Yoshinori Hara, et al. · Journal of Medicinal Chemistry
CCDC 2239439: Experimental Crystal Structure Determination
2023 · Otake, Kazuki, Ubukata, Minoru, et al. · The Cambridge Structural Database
Works count: 11
Citation count: 55
H-index: 3
I10-index: 3
Year
Topic
Type